BloombergLean L·
Novartis CEO Says US China Biotech Curbs Risk Drug Development
Novartis AG Chief Executive Officer Vas Narasimhan said proposed US restrictions on biotech investments in China could hamper the development of new medicines.
Read at Bloomberg →